337 related articles for article (PubMed ID: 32783382)
1. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
Saidoune F; Even G; Lamri Y; Chezel J; Gaston AT; Escoubet B; Papo T; Charles N; Nicoletti A; Sacre K
Arthritis Rheumatol; 2021 Feb; 73(2):255-264. PubMed ID: 32783382
[TBL] [Abstract][Full Text] [Related]
2. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
[TBL] [Abstract][Full Text] [Related]
3. B Cell-Activating Factor Neutralization Aggravates Atherosclerosis.
Tsiantoulas D; Sage AP; Göderle L; Ozsvar-Kozma M; Murphy D; Porsch F; Pasterkamp G; Menche J; Schneider P; Mallat Z; Binder CJ
Circulation; 2018 Nov; 138(20):2263-2273. PubMed ID: 29858401
[TBL] [Abstract][Full Text] [Related]
4. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
5. Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation.
Jackson SW; Scharping NE; Jacobs HM; Wang S; Chait A; Rawlings DJ
J Immunol; 2016 Dec; 197(12):4529-4534. PubMed ID: 27837104
[TBL] [Abstract][Full Text] [Related]
6. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
[TBL] [Abstract][Full Text] [Related]
7. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
8. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
[TBL] [Abstract][Full Text] [Related]
9. B-cell activating factor and A proliferation-inducing ligand in relation to intima-media thickness as biomarkers of premature atherosclerosis in systemic lupus erythematosus patients.
Shater H; Fawzy M; Farid A; El-Amir A; Fouad S; Madbouly N
Am J Med Sci; 2022 Nov; 364(5):646-654. PubMed ID: 35580639
[TBL] [Abstract][Full Text] [Related]
10. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
Yu C; Chen S; Zhou B; Zhang H; Su X; Luo Y; Yang L
Mol Immunol; 2021 Jan; 129():1-11. PubMed ID: 33254074
[TBL] [Abstract][Full Text] [Related]
11. Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.
Yang J; Pospisil R; Ray S; Milton J; Mage RG
PLoS One; 2009 Dec; 4(12):e8494. PubMed ID: 20041151
[TBL] [Abstract][Full Text] [Related]
12. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
[TBL] [Abstract][Full Text] [Related]
13. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
[TBL] [Abstract][Full Text] [Related]
14. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
[TBL] [Abstract][Full Text] [Related]
15. Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.
Du SW; Jacobs HM; Arkatkar T; Rawlings DJ; Jackson SW
J Immunol; 2018 Dec; 201(11):3258-3268. PubMed ID: 30373855
[TBL] [Abstract][Full Text] [Related]
16. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis.
Sánchez-Pérez H; Quevedo-Abeledo JC; de Armas-Rillo L; Rua-Figueroa Í; Tejera-Segura B; Armas-González E; Machado JD; García-Dopico JA; Jimenez-Sosa A; Rodríguez-Lozano C; Díaz-González F; González-Gay MA; Ferraz-Amaro I
Rheumatology (Oxford); 2020 Oct; 59(10):2847-2856. PubMed ID: 32065639
[TBL] [Abstract][Full Text] [Related]
17. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
18. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.
Vincent FB; Saulep-Easton D; Figgett WA; Fairfax KA; Mackay F
Cytokine Growth Factor Rev; 2013 Jun; 24(3):203-15. PubMed ID: 23684423
[TBL] [Abstract][Full Text] [Related]
19. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
Tran NL; Schneider P; Santiago-Raber ML
Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
[TBL] [Abstract][Full Text] [Related]
20. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
Dong G; Yang Y; Li X; Yao X; Zhu Y; Zhang H; Wang H; Ma Q; Zhang J; Shi H; Ning Z; Yan F; Zhai W; Dai J; Li Z; Li C; Ming J; Xue Q; Meng X; Si C; Xiong H
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165554. PubMed ID: 31513833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]